LCLC-97TM1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Human Lung Carcinoma cell line. In vitro etablished from a primary lung large cell carcinoma.
| Product Code | LCLC97TM1 |
| Species | Human |
| Cat.No | ABC-TC600S |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Lung Cancer |
| Storage | Liquid Nitrogen |
| Product Type | Human Lung Cancer Cell Lines |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only
The LCLC-97TM1 cell line has a doubling time of more than 50 hours.
The LCLC-97TM1 cell line is originated from a primary tumor in a 44-year-old man with a large cell lung carcinoma (LCLC), which is a type of non-small cell lung cancer (NSCLC). This cell line is used in cancer research to study the biology of lung cancer, including aspects like tumor growth, metastasis, and drug resistance.
The LCLC-97TM1 cell line has the following culture conditions:
Temperature: Incubate at 37°C
CO2 concentration: Incubate with 5% CO2
Medium: Exchange the culture supernatant at least every second day
Subculture: Split confluent cultures 1:3 to 1:5 once or twice a week using trypsin/EDTA
Seed out: Seed out at approximately 2×10^6 cells/80cm2
